| Pneumoconiosis: current status and future prospects XM Qi, Y Luo, MY Song, Y Liu, T Shu, Y Liu, JL Pang, J Wang, C Wang Chinese medical journal 134 (08), 898-907, 2021 | 115 | 2021 |
| Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages M Song, J Wang, Y Sun, Z Han, Y Zhou, Y Liu, T Fan, Z Li, X Qi, Y Luo, ... Acta Pharmacologica Sinica 43 (5), 1274-1284, 2022 | 57 | 2022 |
| Multi-omics study of silicosis reveals the potential therapeutic targets PGD2 and TXA2 J Pang, X Qi, Y Luo, X Li, T Shu, B Li, M Song, Y Liu, D Wei, J Chen, ... Theranostics 11 (5), 2381, 2021 | 56 | 2021 |
| A novel pathophysiological classification of silicosis models provides some new insights into the progression of the disease Z Cao, M Song, Y Liu, J Pang, Z Li, X Qi, T Shu, B Li, D Wei, J Chen, B Li, ... Ecotoxicology and environmental safety 202, 110834, 2020 | 51 | 2020 |
| Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of β-catenin L Wang, J Liu, W Wang, X Qi, Y Wang, B Tian, H Dai, J Wang, W Ning, ... Thorax 74 (6), 564-578, 2019 | 44 | 2019 |
| Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A Z Cao, Y Liu, Z Zhang, P Yang, Z Li, M Song, X Qi, Z Han, J Pang, B Li, ... Acta Pharmacologica Sinica 43 (4), 908-918, 2022 | 36 | 2022 |
| Inhibition of gasdermin D-dependent pyroptosis attenuates the progression of silica-induced pulmonary inflammation and fibrosis M Song, J Wang, Y Sun, J Pang, X Li, Y Liu, Y Zhou, P Yang, T Fan, Y Liu, ... Acta pharmaceutica Sinica B 12 (3), 1213-1224, 2022 | 36 | 2022 |
| Comparative transcriptome analyses reveal a transcriptional landscape of human silicosis lungs and provide potential strategies for silicosis treatment J Pang, Y Luo, D Wei, Z Cao, X Qi, M Song, Y Liu, Z Li, J Zhang, B Li, ... Frontiers in Genetics 12, 652901, 2021 | 21 | 2021 |
| Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling S Zhang, J Wang, X Qi, X Tao, W Xie, J Wan, YH Shen, Z Zhai Experimental Cell Research 398 (1), 112392, 2021 | 15 | 2021 |
| 3-Bromopyruvate alleviates the development of monocrotaline-induced rat pulmonary arterial hypertension by decreasing aerobic glycolysis, inducing apoptosis, and suppressing … J Liu, W Wang, L Wang, XM Qi, YH Sha, T Yang Chinese Medical Journal 133 (01), 49-60, 2020 | 14 | 2020 |
| Omics approaches for exploring pneumoconiosis: a review LUO Ya, XM Qi, JL Pang, W Jing, W Chen Biomedical and Environmental Sciences 34 (1), 71-82, 2021 | 9 | 2021 |
| Inhibition of immunoglobulin E attenuates pulmonary hypertension T Shu, Y Liu, Y Zhou, Z Zhou, B Li, Y Xing, P Yang, J Pang, J Li, X Song, ... Nature Cardiovascular Research 1 (7), 665-678, 2022 | 4 | 2022 |
| Inactivation of malic enzyme 1 in endothelial cells alleviates pulmonary hypertension Y Luo, X Qi, Z Zhang, J Zhang, B Li, T Shu, X Li, H Hu, J Li, Q Tang, ... Circulation 149 (17), 1354-1371, 2024 | 2 | 2024 |
| Proteome, Lysine Acetylome, and Succinylome Identify Posttranslational Modification of STAT1 as a Novel Drug Target in Silicosis T Zhang, Y Wang, Y Sun, M Song, J Pang, M Wang, Z Zhang, P Yang, ... Molecular & Cellular Proteomics 23 (6), 2024 | | 2024 |
| Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension Y Xing, Y Hou, T Fan, R Gao, X Feng, B Li, J Pang, W Guo, T Shu, J Li, ... Acta Pharmaceutica Sinica B 14 (4), 1726-1741, 2024 | | 2024 |
| Use of Malic Enzyme 1 (ME1) in Preparation of Drug for Preventing and Treating Pulmonary Hypertension (PH) J Wang, X Yanjiang, Y Luo, X Qi US Patent App. 18/332,373, 2024 | | 2024 |
| Silencing Fcgr3 decreases SiO2-induced inflammatory cytokines expression in mouse alveolar macrophage cell line MH-S X LI, X QI, T ZHANG, J WANG Basic & Clinical Medicine 43 (6), 904, 2023 | | 2023 |
